How EnlivenHealth Analytics Tools Helped Magnolia Pharmacy Come Back from Losing Their Biggest Prescriber

At a Glance

When Magnolia Pharmacy in Texas suddenly lost its largest prescriber, owner Steve Hoffart turned to the RxCompass analytics platform (powered by EnlivenHealth Clarity) to recover the lost revenue. Hoffart and his team identified patients late on refills and strategically prioritized outreach by profitability, making the most impactful calls when time was limited. During these calls, staff offered additional services like medication synchronization, vaccinations, and over-the-counter products, transforming what could have been a financial crisis into sustained growth. The pharmacy also used adherence reports to improve Medicare star ratings, which directly impacted profitability through DIR fee structures. The results were remarkable: an 11.4% increase in prescription count, 25% profit increase, 10% profit margin increase, and a 42.2% jump in compound prescriptions—all while strengthening patient relationships and improving health outcomes through better medication adherence.

Background

When Steve Hoffart established Magnolia Pharmacy in Magnolia, Texas in 2002, he had a vision. He wanted to provide the highest quality of care with a comfortable, hometown feel to the people of Magnolia, Texas. Part of that vision involved becoming more than just a traditional fill-and-bill pharmacy. In addition to filling prescriptions, his store offers compounding services, over-the-counter supplements, appointment-based hormone and nutrition counseling, and in-store testing.

But no matter how many services you provide, it’s hard to stay in business when your biggest prescriber suddenly disappears.

Pharmacy: A Volatile Market

As a member of the National Community Pharmacy Association among other pharmacy groups, Hoffart is well versed in the ebbs and flows of the industry. He also knows that staying in business in such a volatile market requires strategy and even a little outside-the-box thinking.

As an American Pharmacies member, Hoffart had access to the RxCOMPASS analytics platform, powered by EnlivenHealth. While he knew data tools could be a game changer, he wouldn’t realize how essential they would be to his independent pharmacy’s survival a short time later.

“Five or ten years ago, we had no data,” says Hoffart. “We didn’t know where to start. As margins in the industries changed, everyone started offering solutions. It’s almost data overload. Now, it’s more an issue of: Where do you focus? Where do you spend your time?”

When Magnolia Pharmacy encountered a provider crisis, Hoffart had no trouble figuring out where to spend his time.

Getting Less Revenue from Fewer Sources

Almost overnight, Magnolia Pharmacy went from financial stability to uncertainty. “I had just hired a brand new pharmacist,” says Hoffart. “Our compounds business had been holding steady. And then we lost the largest practitioner in my area.”

Hoffart explains. “He was with a hospital group, and that group overnight decided they were no longer going to provide primary care services. He was the physician in the building right above me, and he was our largest writer. In a matter of two months, he was gone.”

The situation was made worse by what Hoffart describes as the “race-to-the-bottom mentality” of many pharmacy benefit managers.

“Year after year, our margins have shrunk,” he says. “Each year, the PBMs seem to ask themselves, ‘If we reimburse less, will they still participate?’ Well, of course individual pharmacists and PSAOs are going to sign these contracts. They don’t want to lose patient access.”

And patient access matters. Without worrying about PBM contracts, keeping patients as an independent pharmacy is getting harder and harder. “It seems every month, we lose one or two more to forced mail order or high copays,” says Hoffart.

Getting Back on Track with EnlivenHealth

After losing his largest prescriber, Hoffart turned to Jeff Jacobs, the Pharmacy Operations Manager for American Pharmacies, for help. Jacobs recommended using an RxCompass feature called Refills On Time to help gain back the lost revenue.

Using the data from RxCompass, Hoffart and his staff began contacting patients who were late for their prescription refills. Reaching out to patients directly created an uptick in Magnolia’s revenue — enough of one for Hoffart to breathe a sigh of relief. But once they saw what it could do, they decided to change the way they used the Refills On Time feature.

“Initially, we reviewed the entire list and called every patient,” explains Hoffart. “We got a lot smarter and started using it for profitability.”

Instead of calling every patient on the report, Hoffart and team would sort the list by profitability and use the time they had to call the patients with the most profitable prescriptions. “If we only had thirty minutes that week for phone calls, we would make the most profitable phone calls,” says Hoffart.

The calls started as profitability boosters. Over time, they became opportunity makers. While they were following up on late refills, Magnolia’s staff began offering other services to their patients. They asked patients if they would like to enroll in the pharmacy’s med sync program so they’re not late on further refills. Seeing the opportunity, they soon started asking patients to schedule flu shots or shingles vaccinations while they were on the phone. They even began adding supplements and other over-the-counter medications to prescription refills — refills that, without Refills On Time, never would have come across the counter.

Hoffart also improved his profitability in a more indirect, but still important, way. Using RxCompass’s adherence reports, he was able to pinpoint which customers were hurting his star ratings because of nonadherence. He made a point to call those patients and get them back on their plan. Because of the way DIR fees are structured, star ratings are crucial, says Hoffart. “If you’re not working with your Medicare Part D patients to improve your star score, you’re destroying your profitability.”

“We actually grew during that time. We were able to make up the difference. We did not lose volume — we actually gained volume.”

Steve Hoffart, PharmD, FAAFM, Owner & Pharmacist, Magnolia Pharmacy

What Separates Pharmacies from Other Health Care Practitioners

So what became of Magnolia’s revenue shortfall from losing their biggest prescriber? Thanks to RxCompass and EnlivenHealth, there wasn’t one.

“We actually grew during that time,” says Hoffart. “We were able to make up the difference. We did not lose volume — we actually gained volume.”

The first year after implementing RxCompass, Magnolia Pharmacy saw an 11.4% increase in prescription count, and the number continues to rise. Magnolia also saw a 25% profit increase and a 10% increase in overall profit margin. But it was Magnolia’s compound prescriptions that benefitted the most from FDS’s data tools, increasing by 42.2% since they started using RxCompass.

And as for the prescriber who started all of this? “Oh, we got that physician back now,” adds Hoffart. “He’s with a different hospital group.”

Magnolia Pharmacy also used RxCompass to take patient care to a new level.  With the help of the adherence reports and their patient outreach efforts, they were able to raise their star ratings across the board. For patients over 65, ratings in proportion of days covered for Diabetes and Cholesterol grew by two and three stars, respectively.

And making the adherence phone calls helped them forge better patient relationships. “That is what separates pharmacy from any other healthcare practitioners,” says Hoffart. “It’s the patient touches.”

“That’s Why We Do This Every Day.”

For Steve Hoffart, making the most of patient interactions was the key to improving both the health of his patients and his business. By combining data tools like Refills On Time and Adherence Reports with his medication synchronization program, he was able to turn what could have been a financial crisis into a period of sustained growth.

As it turns out, patient adherence and pharmacy profitability are connected.

“It is so critical to fill every prescription for every patient possible,” he says. “Not only does it help [the pharmacy] financially, but adherence improves outcomes.

“And, really, that’s why we do this every day — to make sure our patients are well.”

Results

11.4% Increase in Prescription Count: Despite losing their largest prescriber, Magnolia not only recovered but grew their prescription volume over the course of the year, demonstrating that strategic patient outreach can overcome even significant disruptions to revenue sources.

25% Increase in Pharmacy Profits: By focusing on high-value patient interactions and adherence improvements with RxCompass and EnlivenHealth Clarity, the pharmacy transformed profitability without simply increasing volume, proving that smarter operations drive better financial outcomes.

10% Increase in Profit Margin: This improvement in margin shows that data-driven patient care isn't just about doing more—it's about working more profitably, which is critical in an environment where PBM reimbursements continue to decline.

42.2% Increase in Compound Prescription Count: Compound prescriptions represent higher-margin opportunities for independent pharmacies, and this dramatic growth demonstrates how targeted outreach can drive patients toward specialized services that differentiate the pharmacy from chain competitors.

Significant Star Rating Increases in 2 Categories: Identifying and addressing patients with adherence issues enabled Magnolia Pharmacy to raise their adherence scores, getting a two-star increase for PDC - Diabetes and a three-star increase for PDC - Cholesterol.

For More Information

To learn more about how you can use data analytics to increase script counts and grow your pharmacy profits, reach out to EnlivenHealth today!

‍

‍

‍

EnlivenHealth and the EnlivenHealth logo are registered trademarks of EnlivenHealth, Inc. All other names, trademarks, or brands that may be mentioned in this report are the property of their respective owners. Use of these names, trademarks, or brands does not imply endorsement.

‍